SCHEMBL20474248

SCHEMBL20474248

COC(=O)c1cnc2cc(NC(C)=O)ccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.59
KDM4E B2RXH2 5/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
GLA P06280 1/20 0.59
TNNI3 P19429 1/20 0.59
TNNT2 P45379 1/20 0.59
TNNC1 P63316 1/20 0.59
RUNX1 Q01196 1/20 0.59
CBFB Q13951 1/20 0.59
PABPC1 P11940 1/20 0.49
HPGDS O60760 6/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17967325 0.86 KDM4E (0.62) MAPTKDM4EMEN1KMT2ANPC1
SCHEMBL12948580 0.80 NPC1 (0.66) MAPTKDM4EMEN1KMT2ANPC1
SCHEMBL1043657 0.80 HPGDS (0.52) KDM4EHPGDSALOX15HTTPSMD14
SCHEMBL17221411 0.80 MAOB (0.53) MAPTKDM4ENPC1RAB9AHPGDS
SCHEMBL975217 0.79 KDM4E (0.60) MAPTKDM4EMEN1KMT2ANPC1
SCHEMBL3589284 0.79 MGLL (0.49) MAPTNPC1RAB9AHPGDSSMN1; SMN2
SCHEMBL3575601 0.78 HPGDS (0.54) MAPTRAB9AHPGDSSMN1; SMN2ALOX15
SCHEMBL19021550 0.78 HPGDS (0.74) HPGDS
SCHEMBL2001821 0.78 HPGDS (0.51) HPGDSALOX15HTTPSMD14
SCHEMBL20741514 0.78 KDM4E (0.64) MAPTKDM4EMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF ABL1, FLT3, MAP3K7 MAPT 2812/4885KDM4E 892/4885MEN1 1506/4885
US-10227355-B2 Quinoline derivatives and preparation thereof ABL1, FLT3, MAP3K7 MAPT 2415/4885KDM4E 939/4885MEN1 1505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.